DK142543B - Analogous process for the preparation of bis (benzamido) benzoic acid derivatives or pharmaceutically acceptable salts thereof. - Google Patents

Analogous process for the preparation of bis (benzamido) benzoic acid derivatives or pharmaceutically acceptable salts thereof. Download PDF

Info

Publication number
DK142543B
DK142543B DK166774AA DK166774A DK142543B DK 142543 B DK142543 B DK 142543B DK 166774A A DK166774A A DK 166774AA DK 166774 A DK166774 A DK 166774A DK 142543 B DK142543 B DK 142543B
Authority
DK
Denmark
Prior art keywords
bis
water
acid
mixture
solution
Prior art date
Application number
DK166774AA
Other languages
Danish (da)
Other versions
DK142543C (en
Inventor
Takashi Mori
Sakae Takaku
Yoshiyuki Osugi
Takashi Matsuno
Shogo Tomizawa
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DK142543B publication Critical patent/DK142543B/en
Application granted granted Critical
Publication of DK142543C publication Critical patent/DK142543C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

(11) FREMLÆGGELSESSKRIFT 1 42543 DANMARK <«'> In«. Cl.· C 07 C 103/76 «(21) Ansøgning nr. 1 667/74 (22) Indleveret den 26. HIST. 1974 (24) Løbedag 26. mar. 1974 (44) Ansøgningen fremlagt og fremlæggelsesskriftet offentliggjort den 17· ΠΟΥ · 1 980(11) PRESENTATION 1 42543 DENMARK <«'> In«. Cl. C 07 C 103/76 '(21) Application No 1 667/74 (22) Filed on the 26th HIST. 1974 (24) Race day 26 Mar 1974 (44) The application presented and the petition published on 17 · ΠΟΥ · 1 980

DIREKTORATET FORDIRECTORATE OF

PATENT- OG VAREMÆRKEVÆSENET 00) Prioritet begæret fra denPATENT AND TRADEMARKET SYSTEM 00) Priority requested from it

27. mar. 1973, 34152/73, JPMar 27 1973, 34152/73, JP

(71) CHUG AI SEIYAKU KABUSHIKI KAISHA, 5-1, 5-chorae, Ukima, Kita-ku, Tokyo, JP.(71) CHUG AI SEIYAKU KABUSHIKI KAISHA, 5-1, 5-chorae, Ukima, Kita-ku, Tokyo, JP.

(72) Opfinder: Takashi Mori, 2-8-302, Nagayama 4-chome, Tama-shi, Tokyo, JP: Sakæ Takaku, T-11-404, Nishiageo-Dainidanchi, 77-1, Oazakoshi= kiya, Ageo-shi, Saitama-ken, JP: Yoshiyuki Osugi, 373, Nakamachi, Ko= daira-shi, Tokyo, JP: Takashi Matsuno, 1-2-"408, Shimura 1-chotne, Ita= bashi-ku, Tokyo, JP: Shogo TotriTzawa, 3-3-402, Nagayama 3-chome, Tams-shi, Tokyo, JP.(72) Inventor: Takashi Mori, 2-8-302, Nagayama 4-chome, Tama-shi, Tokyo, JP: Sakæ Takaku, T-11-404, Nishiageo-Dainidanchi, 77-1, Oazakoshi = kiya, Ageo- shi, Saitama-ken, JP: Yoshiyuki Osugi, 373, Nakamachi, Ko = daira-shi, Tokyo, JP: Takashi Matsuno, 1-2- "408, Shimura 1-chotne, Ita = bashi-ku, Tokyo, JP: Shogo TotriTzawa, 3-3-402, Nagayama 3-chome, Tams-shi, Tokyo, JP.

(74) Fuldmægtig under segens behandling:(74) Plenipotentiary under the blessing:

Internationalt Patent-Bureau. ____ (54) Analogifremgangsmåde til fremstilling af bis-(benzamido)-benzoesyre derivater eller farmaceutisk acceptable salte deraf.International Patent Office. ____ (54) Analogous process for preparing bis- (benzamido) -benzoic acid derivatives or pharmaceutically acceptable salts thereof.

Opfindelsen angår en analogifremgangsmåde til fremstilling af hidtil ukendte bis-(benzamido)-benzoesyrederivater med den almene formel I (se kravet), hvori betegner en hydroxylgruppe, en C.. .-alkoxygruppe eller en aminogruppe, 2 i-^ og R betegner et hydrogenatom, en C^_^-alkanoylgruppe, eller en ^-alkyl- gruppe, eller farmakologisk acceptable salte deraf.The invention relates to an analogous process for the preparation of novel bis (benzamido) benzoic acid derivatives of general formula I (see claim), wherein a hydroxyl group, a C 1-4 alkoxy group or an amino group, 2 hydrogen atom, a C 1-6 alkanoyl group, or a C 1-4 alkyl group, or pharmacologically acceptable salts thereof.

Fremgangsmåden er ifølge opfindelsen ejendommelig ved, at man omsætter en forbindelse med formlen II (se kravet), hvori R^- har den ovenfor anførte be- 2 tydning, med en carboxylsyre med formlen III (se kravet), hvori R har den ovenfor anførte betydning, eller med et reaktionsdygtigt derivat af syren, og om ønsket hydrolyserer estergrupper i produktet eller acylerer to phenoliske hydroxylgrupper i produktet, eller, såfremt forbindelsen med formlen I indeholder en carboxylgruppe, overfører forbindelsen i et farmaceutisk acceptabelt 2 142543 salt.The process according to the invention is characterized by reacting a compound of formula II (see claim) wherein R 2 - has the meaning given above, with a carboxylic acid of formula III (see claim) wherein R has the above or, if desired, hydrolyzes ester groups in the product or acylates two phenolic hydroxyl groups in the product or, if the compound of formula I contains a carboxyl group, transfers the compound into a pharmaceutically acceptable salt.

Eksempler på forbindelser med formlen II, der kan anvendes som udgangsmaterialer er 3,5-diaminobenzoesyre, 3,4-diaminobenzoesyre, 2,4-diamino-benzoesyre, 2,5 -diaminobenzoesyre og alkylestere af diaminobenzoesyre (idet antallet af carbonatomer i alkylgruppen andrager mellem 1 og 4), f.eks. methyl- 2, 4-diaminobenzoat, ethyl-2,4-diaminobenzoat, butyl-2,4-diaminobenzoat og methyl- 3, 5-diaminobenzoat, og 2,4-diaminobenzamid og 3,5-diaminobenzamid.Examples of compounds of formula II which can be used as starting materials are 3,5-diaminobenzoic acid, 3,4-diaminobenzoic acid, 2,4-diamino benzoic acid, 2,5-diamino benzoic acid and alkyl esters of diaminobenzoic acid (the number of carbon atoms in the alkyl group being between 1 and 4), e.g. methyl 2,4-diaminobenzoate, ethyl 2,4-diaminobenzoate, butyl 2,4-diaminobenzoate and methyl 3,5-diaminobenzoate, and 2,4-diaminobenzamide and 3,5-diaminobenzamide.

Forbindelserne med formlerne III og reaktionsdygtige derivater deraf, der kan anvendes som udgangsmaterialer omfatter salicylsyre, 2-alkoxybenzoesyre, hvori antaller af carbonatomer i alkyldelen er mellem 1 og 4, f.eks. 2-methoxy-benzoesyre, 2-ethoxybenzoesyre og 2-n-butoxybenzoesyre, 2-alkanoyloxybenzoesyre, hvori antallet af carbonatomer i alkyldelen er mellem 1 og 4, f.eks. 2-acetoxy-benzoesyre, og tilsvarende halogenider, estere, syreanhydrider og anhydrider af de nævnte syrer med andre syrer, såsom andre carboxylsyrer, kulsyrer, svovlsyrer, sulfonsyrer og phosphorsyrer.The compounds of formulas III and their reactive derivatives which can be used as starting materials include salicylic acid, 2-alkoxybenzoic acid, wherein numbers of carbon atoms in the alkyl moiety are between 1 and 4, e.g. 2-methoxybenzoic acid, 2-ethoxybenzoic acid and 2-n-butoxybenzoic acid, 2-alkanoyloxybenzoic acid wherein the number of carbon atoms in the alkyl moiety is between 1 and 4, e.g. 2-acetoxy-benzoic acid, and corresponding halides, esters, acid anhydrides and anhydrides of said acids with other acids such as other carboxylic acids, carbonic acids, sulfuric acids, sulfonic acids and phosphoric acids.

Reaktionen kan f.eks. udføres ved, at man underkaster en forbindelse med f ormlen II en kondensationsreaktion med et reaktionsdygtigt derivat af en carboxylsyre med formlen III ved en temperatur på fra sædvanligvis mellem -10 og 50°C, fortrinsvis mellem 0 og 20°C i et tidsrum mellem 30 minutter og 4 timer.The reaction may, e.g. is carried out by subjecting a compound of formula II to a condensation reaction with a reactive derivative of a carboxylic acid of formula III at a temperature of usually between -10 and 50 ° C, preferably between 0 and 20 ° C for a period between 30 minutes and 4 hours.

Som eksempler på opløsningsmidler, der kan anvendes ved denne reaktion, kan nævnes vand, benzen, toluen, tetrahydrofuran, diethylether, dioxan, dimethyl-formamid, chloroform, methylenchlorid, acetonitril, acetone, tetrachlormethan, ethylacetat og blandinger heraf.Examples of solvents which can be used in this reaction include water, benzene, toluene, tetrahydrofuran, diethyl ether, dioxane, dimethylformamide, chloroform, methylene chloride, acetonitrile, acetone, tetrachloromethane, ethyl acetate and mixtures thereof.

Som eksempler på acceleratorer, der kan anvendes ved reaktionen, kan nævnes uorganiske baser, såsom hydroxider, carbonater og acetater af alkalimetaller eller jordalkalimetalier, f.eks. kaliumacetat, natriumacetat, natriumcarbonat, kaliumcarbonat, natriumhydroxid, calciumacetat og calciumcarbonat, og organiske tertiære aminbaser, f.eks. pyridin, triethylamin, dimethylanilin og picolin.Examples of accelerators that can be used in the reaction include inorganic bases such as hydroxides, carbonates and acetates of alkali metals or alkaline earth metals, e.g. potassium acetate, sodium acetate, sodium carbonate, potassium carbonate, sodium hydroxide, calcium acetate and calcium carbonate, and organic tertiary amine bases, e.g. pyridine, triethylamine, dimethylaniline and picoline.

Man kan endvidere omsætte en forbindelse med formlen II, hvis aminogrupper er aktiveret under anvendelse af phosphortrichlorid eller en ester af chlorphosphorsyrling, med en forbindelse med formlen III ved en temperatur mellem stuetemperatur og tilbagesvalingstemperaturen for det anvendte opløsningsmiddel. Det foretrækkes at udføre denne reaktion efter at hydroxylgrup-pen i forbindelse II er beskyttet, hvis R betegner hydroxyl. Reaktionen udføres under tilstedeværelse af et opløsningsmiddel, f.eks. et neutralt opløsningsmiddel, såsom benzen, toluen, xylen, dioxan eller tetrahydrofuran eller i et basisk opløsningsmiddel, såsom pyridin, triethylamin, dimethylanilin eller picolin.In addition, a compound of formula II, whose amino groups are activated using phosphorus trichloride or an ester of chlorophosphoric acid, can be reacted with a compound of formula III at a temperature between room temperature and the reflux temperature of the solvent used. It is preferred to carry out this reaction after the hydroxyl group of compound II is protected if R represents hydroxyl. The reaction is carried out in the presence of a solvent, e.g. a neutral solvent such as benzene, toluene, xylene, dioxane or tetrahydrofuran or in a basic solvent such as pyridine, triethylamine, dimethylaniline or picoline.

Hvis reaktionen udføres under tilstedeværelse af et neutralt opløsningsmiddel, foretrækkes det at anvende en tertiær amin som accelerator. Reaktionstiden andrager mellem 30 minutter og 3 timer.If the reaction is carried out in the presence of a neutral solvent, it is preferable to use a tertiary amine as an accelerator. The reaction time is between 30 minutes and 3 hours.

3 1425Λ33 1425Λ3

Ved en anden udførelsesform for fremgangsmåden kan en forbindelse med formlen II omsættes med en forbindelse med formlen III i et indifferent organisk opløsningsmiddel under tilstedeværelse af en som accelerator for amiddannelse virkende forbindelse, såsom dicyclohexylcarbodiimid ved en temperatur mellem stuetemperatur og tilbagesvalingstemperatur for det anvendte opløsningsmiddel og under anvendelse af en reaktionstid på 1-5 timer. I tilfælde af at forbindelsen II har en hydroxylgruppe foretrækkes det at beskytte denne gruppe før reaktionen. Opløsningsmidler, der kan anvendes ved reaktionen omfatter benzen, toluen, tetra-hydrofuran, chloroform, methylenchlorid, acetonitril og lignende.In another embodiment of the process, a compound of formula II can be reacted with a compound of formula III in an inert organic solvent in the presence of an amide-accelerating compound such as dicyclohexylcarbodiimide at a temperature between room temperature and reflux temperature of the solvent used and below. using a reaction time of 1-5 hours. In case compound II has a hydroxyl group, it is preferred to protect this group prior to the reaction. Solvents which may be used in the reaction include benzene, toluene, tetrahydrofuran, chloroform, methylene chloride, acetonitrile and the like.

Den nævnte hydrolyse af en forbindelse med formlen I, som har estergrupper kan f.eks. foretages ved indvirkning af et hydroxid eller et carbonat af alkalimetal eller jordalkalimetal i vand eller i et vandigt organisk opløsningsmiddel ved en temperatur på fra stuetemperatur til 100°C i en halv til 30 timer. Acylering af de. phenoliske hydroxylgrupper kan ske ved indvirkning af et syrechlorid eller et syreanhydrid af en lavere fed syre ved 0-100°C i 1-10 : timer. Anvendelse af et opløsningsmiddel er ikke nødvendigt, men der kan anvendes et indifferent opløsningsmiddel, såsom tetrahydrofuran, dioxan eller acetone/ En basisk accelerator, såsom pyridin, triethylamin eller natriumacetat eller en sur accelerator, såsom svovlsyre eller p-toluensulfonsyre kan passende anvendes.Said hydrolysis of a compound of formula I which has ester groups can e.g. is carried out by the action of a hydroxide or carbonate of alkali metal or alkaline earth metal in water or in an aqueous organic solvent at a temperature of from room temperature to 100 ° C for half to 30 hours. Acylation of the. phenolic hydroxyl groups may be effected by the action of an acid chloride or an acid anhydride of a lower fatty acid at 0-100 ° C for 1-10: hours. Use of a solvent is not necessary, but an inert solvent such as tetrahydrofuran, dioxane or acetone may be used. A basic accelerator such as pyridine, triethylamine or sodium acetate or an acidic accelerator such as sulfuric acid or p-toluenesulfonic acid may be suitably used.

Hvis produktet har en fri carboxylsyregruppe kan et farmakologisk acceptabelt salt deraf anvendes til samme formål som produktet.If the product has a free carboxylic acid group, a pharmacologically acceptable salt thereof can be used for the same purpose as the product.

Forbindelserne med formlen I har karakteristiske biologiske virkninger, navnlig på antigen-antistof-reaktioner. Det er f.eks. iagttaget ved in vitro forsøg, at de vandopløselige forbindelser med formlen I selv i meget ringe mængde kan hæmme hæmolyse af røde blodlegemer fra får, som indtræder ved reaktion mellem de røde blodlegemer og anti-(røde blodlegemer fra får)-museserum under tilstedeværelse af komplement (immun hæmolyse). Ved dyreforsøg hæmmer forbindelserne med formlen I i høj grad cutan anaphylaktisk reaktion ved oral administrering i en dosis op til 100 mg/kg.The compounds of formula I have characteristic biological effects, especially on antigen-antibody reactions. It is e.g. observed in in vitro experiments that the water-soluble compounds of formula I can inhibit even very small amounts of red blood cell haemolysis, which occurs by reaction between the red blood cells and anti (sheep red blood cells) in the presence of complement (immune hemolysis). In animal studies, the compounds of formula I greatly inhibit cutaneous anaphylactic reaction by oral administration at a dose up to 100 mg / kg.

Forbindelserne med fomlen I hæmmer ikke alene sådanne immunreaktioner som angivet ovenfor, men har også en antipyretisk, sedativ, antiinflammatorisk og antiallergisk virkning. Forbindelserne er navnlig egnede til behandling af sygdomme, der skyldes immunologiske forstyrrelser, f.eks. rheumatisk arthritisk, bronchial astma og nephritis.The compounds of fomel I not only inhibit such immune responses as indicated above, but also have an antipyretic, sedative, anti-inflammatory and antiallergic effect. The compounds are particularly useful for treating diseases caused by immunological disorders, e.g. rheumatic arthritic, bronchial asthma and nephritis.

Opfindelsen illustreres nærmere ved hjælp af følgende forsøg og eksempler.The invention is further illustrated by the following experiments and examples.

4 1425434 142543

Fors jig 1 Hæmning af varme-induceret hasmolyse.Experiment 1 Inhibition of heat-induced hasholysis.

Røde blodlegemer fra en Wister-Imamichi-rotte af hankøn blev suspenderet i 0,15 M phosphatstødpude (pH-værdi 7,4) til opnåelse af en 1%'s suspension af røde blodlegemer. I et reagensglas blev indført 5 ml af suspensionen og derpå 0,1 mm 10%'s opløsning af dimethylsulfoxid i ethanol indeholdende den forbindelse, der skulle prøves, hvorpå der blev inkuberet ved 53°C i 20 minutter. Reagensglasset blev derpå afkølet med vand, og indholdet af røret blev centrifugeret ved 2000 omdrejninger pr. minut i 10 minutter. Den optiske tæthed af den Øvre væske, der således blev opnået, blev målt med et Hitachi-124-spektrofotometer ved 540 ιαχύ. Hæmningen af hæmolysen blev beregnet ud fra nedenstående ligning.Red blood cells from a male Wister-Imamichi rat were suspended in 0.15 M phosphate buffer (pH 7.4) to obtain a 1% red blood cell suspension. Into a test tube was introduced 5 ml of the suspension and then 0.1 mm 10% solution of dimethyl sulfoxide in ethanol containing the compound to be tested and then incubated at 53 ° C for 20 minutes. The test tube was then cooled with water and the contents of the tube were centrifuged at 2000 rpm. minute for 10 minutes. The optical density of the Upper Liquid thus obtained was measured with a Hitachi-124 spectrophotometer at 540 ιαχύ. The inhibition of hemolysis was calculated from the equation below.

Hæmolysehæmning (%) = (absorption af inkuberet absorption af ikke-inkuberet \ suspension indeholdende - suspension uden prøveforbin- \ prøveforbindelsen delse 1 -------x 100 absorption af inkuberet absorption af ikke-inkuberet ! suspension uden prøve- - suspension uden prøveforbin-forbindeIse delse /Hemolysis Inhibition (%) = (Absorption of Incubated Absorption of Unincubated \ Suspension Containing - Suspension without Sample Compound \ Sample Compound 1 ------- x 100 Absorption of Incubated Absorption of Unincubated Suspension without Sample Suspension without trial connection /

Resultaterne er vist i nedenstående tabel 1.The results are shown in Table 1 below.

Tabel 1Table 1

Forbindelse HæmolysehæmningCompound Hemolysis inhibition

Forbindelse ifølge eksempel 1 +++ II II "2 +++ II II II 3 ++.Compound of Example 1 +++ II II "2 +++ II II II 3 ++.

tt n n 4 +4- II II II 5 -HH*tt n n 4 + 4- II II II 5 -HH *

II il ti 6 -f+TII il ti 6 -f + T

11 II II 7 -H- ii ii " 8 +++ μ ir ii 9 + " II 1' 10 ++ II ii n il + ii it ii 12 + ii ti ii 13 + ii ii ii 14 ++ ii ii ” 17 ++t 5 14254311 II II 7 -H- ii ii "8 +++ µ ir ii 9 +" II 1 '10 ++ II ii n il + ii it ii 12 + ii ti ii 13 + ii ii ii 14 ++ ii ii " 17 ++ t 5 142543

Tabel 1 (fortsat)Table 1 (continued)

Forbindelse Haano lyse hagglingConnection Haano bright haggling

Forbindelse ifølge eksempel 18 ++TCompound of Example 18 ++ T

ti π ii 19 +++ ii ’’ " 20 + " " " 22 + " " " 23 ++ti π ii 19 +++ ii '' "20 +" "" 22 + "" "23 ++

Benzidamin +Benzidamine +

Phenylbutazonphenylbutazone

Salicylsyre N-(2,3—xylyl)-anthranilsyre + +++: Over 80%'s hæmning ved 1 x 10-½ -H-T: Ga. 50%'s haamning ved 1 x 10-½Salicylic acid N- (2,3-xylyl) -anthranilic acid + +++: Over 80% inhibition at 1 x 10 -½-H-T: Ga. 50% hamstring at 1 x 10-½

("Mindre end 20%'s hæmning ved 1 x 10-½ eller (.Over 80%'s hæmning ved 1 x 1(T4M("Less than 20% inhibition at 1 x 10-½ or (. Over 80% inhibition at 1 x 1 (T4M

-4-4

+: Ga. 50%'s hæmning ved 1 x 10 M+: Go. 50% inhibition at 1 x 10 M

-4-4

Mindre end 20%'s hæmning ved 1 x 10 MLess than 20% inhibition at 1 x 10 M

Forsøg 2 Hæmning af ved immunreaktion induceret hæmolyse.Experiment 2 Inhibition of hemolysis induced by immune response.

Følgende fire opløsninger blev fremstillet.The following four solutions were prepared.

A. Antiserumopløsning.A. Antiserum solution.

Kommercielt tilgængeligt fåreblod blev vasket 3 gange med en fysiologisk saltopløsning og centrifugeret ved 2000 omdrejninger pr. minut i 5 minutter. En ml præcipiterede blodlegemer blev gensuspenderet i 10 ml fysiologisk saltopløsning. Den resulterende opløsning blev injiceret intravenøst hos mus (IV cs 5W) i en dosis på 0,2 ml, og 4 dage efter injektionen blev der udtaget en blodprøve fra musene. Fra denne prøve blev serum indeholdende anti-(fåreblodlegemer)-antistof udvundet og til opnåelse af en anti-serumopløsning fortyndet til 40 gange * · ++ det oprindelige volumen med en opløsning, der i det følgende er betegnet GVB , og som er en stødpudeopløsning med en pH-værdi på 7,5, og som indeholder gela-tine, Ca og Mg . Denne stødpudeopløsning fremstilles ud fra følgende bestanddele: 5,5-diethylbarbitursyre 0,575 g.Commercially available sheep blood was washed 3 times with a physiological saline solution and centrifuged at 2000 rpm. minute for 5 minutes. One ml of precipitated blood cells was resuspended in 10 ml of physiological saline solution. The resulting solution was injected intravenously into mice (IV cs 5W) at a dose of 0.2 ml, and 4 days after injection a blood sample was taken from the mice. From this sample, serum containing anti (sheep blood cell) antibody was recovered and to obtain an anti-serum solution diluted to 40 times * · ++ the original volume with a solution hereinafter referred to as GVB, which is a buffer solution having a pH of 7.5 and containing gelatin, Ca and Mg. This buffer solution is prepared from the following ingredients: 5,5-diethylbarbituric acid 0.575 g.

natrium - 5,5 - diethylbarbiturat 0,375 gsodium - 5.5 diethyl barbiturate 0.375 g

CaCl2, 2H20 0,022 gCaCl 2, 2H 2 O 0.022 g

MgCl2, 6H20 0,1017 g gelatine 1 gMgCl2, 6H2O 0.1017 g gelatin 1 g

NaCl 8,5 g 6 U2543 destilleret vand ad 1 liter.NaCl 8.5 g of 6 U2543 distilled water in 1 liter.

B. Komplementopløsning.B. Complement solution.

Som komplementkilde blev anvendt serum fra marsvin. Marsvineserum blevAs a source of complement, guinea pig serum was used. Guinea pig serum became

I II I

fortyndet til 40 gange dets oprindelige volumen med (GVB ) til opnåelse af en komplementopløsning. Alle processer ved fremstilling af opløsningen blev udført under afkøling.diluted to 40 times its original volume with (GVB) to obtain a complement solution. All processes of preparing the solution were carried out under cooling.

C. Blodlegemesuspension.C. Blood cell suspension.

-hl·-hI ·

Blodlegemer blev suspenderet i GVB . 0,25 ml af suspensionen blev fuldstændigt hæmolyseret med vand til et volumen på 3,3 ml. Derpå blev den resulterende suspension fremstillet således, at den optiske tæthed blev 0,455 ved 541n^ ved hæmolysens afslutning.Blood cells were suspended in GVB. 0.25 ml of the suspension was completely hemolysed with water to a volume of 3.3 ml. Then, the resulting suspension was prepared such that the optical density became 0.455 at 541n 2 at the end of hemolysis.

D. Prøveopløsning.D. Sample Solution.

-H--H-

Forbindelsen, der skulle prøves, blev opløst i GVB til opnåelse af en koncentration 1,5 gange større end den forudbestemte endelige koncentration.The compound to be tested was dissolved in GVB to obtain a concentration 1.5 times greater than the predetermined final concentration.

Til 2 ml af prøveopløsningen blev sat 0,5 ml af antiserumopløsningen, 0,25 ml blodlegemesuspension og 0,25 ml af komplementopløsningen, og blandingen blev inkuberet ved 27°C i 40 minutter. Derpå blev der til reaktionsblandingen sat 0,3 ml 3,8 %'s vandig trinatriumcitratopløsning til afslutning af reaktionen. Ikke-hæmolyserede blodlegemer blev adskilt fra blandingen ved centrifugering i 5 minutter ved 2000 omdrejninger pr. minut. Absorptionen af den øvre væske blev målt ved 541 mfi·.To 2 ml of the sample solution was added 0.5 ml of the antiserum solution, 0.25 ml of blood cell suspension and 0.25 ml of the complement solution, and the mixture was incubated at 27 ° C for 40 minutes. Then 0.3 ml of 3.8% aqueous trisodium citrate solution was added to the reaction mixture to complete the reaction. Non-hemolysed blood cells were separated from the mixture by centrifugation for 5 minutes at 2000 rpm. minute. The absorption of the upper fluid was measured at 541 mfi ·.

Separat blev et kontrolforsøg udført på lignende måde som anført ovenforSeparately, a control experiment was performed in a similar manner as stated above

j Jj J

med den afvigelse, at der blev anvendt 2 ml GVB uden prøveforbindelse.with the exception that 2 ml of non-test compound GVB was used.

Yderligere blev en blindprøve foretaget ved hvert forsøg efter samme me- +4- todik som anført ovenfor med den afvigelse, at 0,25 ml GVB blev anvendt i stedet for 0,25 ml af komplementopløsningen, og forsøgsfejl forårsaget af farvning af prøveopløsningen blev korrigeret.In addition, a blank test was performed on each experiment following the same method + 4 method as stated above with the exception that 0.25 ml GVB was used instead of 0.25 ml of the complement solution and test errors caused by staining the sample solution were corrected. .

Hæmolysehæmningen (%) blev beregnet efter følgende ligning: Hæmolysehæmning (%) = /' absorption af prøve absorption af tilsva- \ / indeholdende prøvefor- - rende blindprøve \ bindeIse \ I-----—- x 100The hemolysis inhibition (%) was calculated according to the following equation: Hemolysis inhibition (%) = / Absorption of sample Absorption of equivalent- containing sample-containing blank sample \ binding \ I -----—- x 100

absorption af kontrol- absorption af kontrol- Iabsorption of control- absorption of control- I

prøven - prøven ved blindforsøgetythe sample - the sample at blank test time

Det opnåede resultater er anført i nedenstående tabel 2.The results obtained are listed in Table 2 below.

7 1425437 142543

Tabel 2Table 2

Forbindelse HamolysehæmningCompound Hamolysis Inhibition

Forbindelse ifølge eksempel 1 +++ » » " 2 +++ » " " 8 +++ N-(2,3—xylyl)-anthranilsyre +Compound of Example 1 +++ »» "2 +++" "" 8 +++ N- (2,3-xylyl) -anthranilic acid +

Dinatriumchromoglycat +Disodium Chromoglycate +

Salicylsyresalicylic acid

Phenylbutazon ++Phenylbutazone ++

Over 50%'s hæmning ved 3,5 x 10~^M eller over 80%'s hæmning ved 8,8 x 10-½ ++: 50-80%'s hæmning ved 8,8 x 10_Sl -4Above 50% inhibition at 3.5 x 10 ~ ^ M or over 80% inhibition at 8.8 x 10-½ ++: 50-80% inhibition at 8.8 x 10_Sl -4

+: 20-50%'s hæmning ved 8,8 x 10 M+: 20-50% inhibition at 8.8 x 10 M

-4-4

Under 20%'s hæmning ved 8,8 x 10 MBelow 20% inhibition at 8.8 x 10 M

Eksempe1 1Example1 1

En opløsning af 17,5 g 2-acetoxybenzoylchlorid i 20 ml dioxan blev på én gang sat til en blanding af 4,6 g 3,5-diaminobenzoesyre, 15,3 g kaliumacetat og 80 ml vand under omrøring ved en temperatur på mellem 0 og 5°C. Omrøringen blev fortsat ved denne temperatur i 1 time, og derpå ved stuetemperatur i 30 minutter og ved 50°C i 30 minutter. Den resulterende reaktionsblanding blev sat til 20 ml kold fortyndet saltsyre, og ikke opløst stof blev fraskilt. Dette støf blev opløst i ca. 100 ml IN vandig NaOH-opløsning,og derpå blev opløsningen behandlet med aktivt kul og syrnet med saltsyre, til opnåelse af en pH-værdi på 3-4, hvorved der udskiltes krystaller. Krystallerne blev fjernet og vasket med vand. Omkrystallisation fra methanol-vand gav 7,2 g 3,5-bis(salicylamido)-ben-zoesyre med et smp. mellem 305 og 308°C ( sønderdeling).A solution of 17.5 g of 2-acetoxybenzoyl chloride in 20 ml of dioxane was added at once to a mixture of 4.6 g of 3,5-diaminobenzoic acid, 15.3 g of potassium acetate and 80 ml of water while stirring at a temperature of between 0 and 5 ° C. Stirring was continued at this temperature for 1 hour, then at room temperature for 30 minutes and at 50 ° C for 30 minutes. The resulting reaction mixture was added to 20 ml of cold dilute hydrochloric acid and no solute was separated. This dust was dissolved in ca. 100 ml of 1N aqueous NaOH solution, and then the solution was treated with activated charcoal and acidified with hydrochloric acid to give a pH of 3-4, thereby separating crystals. The crystals were removed and washed with water. Recrystallization from methanol-water gave 7.2 g of 3,5-bis (salicylamido) benzoic acid, m.p. between 305 and 308 ° C (dec.).

Analyse:Analysis:

Beregnet: C 64,3, H 4,1, N 7,1 (%)Calculated: C 64.3, H 4.1, N 7.1 (%)

Fundet: C 64,5, H 4,1, N 7,1 (%)Found: C 64.5, H 4.1, N 7.1 (%)

Eksempel 2Example 2

En opløsning af 17,2 g 2-acetoxybenzoylchlorid i 20 ml dioxan blev på én gang sat til en blanding af 4,6 g 3,4-diaminobenzoesyre, 15,3 g kaliumacetat og 70 ml vand under omrøring ved en temperatur på mellem 0 og 5°C, efterfulgt af omrøring ved denne temperatur i 30 minutter. Til blandingen blev sat en opløsning af 1 g 2-acetoxybenzoylchlorid i 3 ml dioxan. Den resulterende blanding blev omrørt ved stuetemperatur i 30 minutter og derpå ved 50°C i 30 minutter.A solution of 17.2 g of 2-acetoxybenzoyl chloride in 20 ml of dioxane was added at once to a mixture of 4.6 g of 3,4-diaminobenzoic acid, 15.3 g of potassium acetate and 70 ml of water under stirring at a temperature of between 0 and 5 ° C, followed by stirring at this temperature for 30 minutes. To the mixture was added a solution of 1 g of 2-acetoxybenzoyl chloride in 3 ml of dioxane. The resulting mixture was stirred at room temperature for 30 minutes and then at 50 ° C for 30 minutes.

U 2543 8U 2543 8

Reaktionsblandingen blev sat til 200 ml kold fortyndet saltsyre, og den ikke opløste blanding af olie og pulverformet fast stof blev isoleret. Blandingen blev opløst i ca. 100 ml vandig IN natriumhydroxidopløsning, og opløsningen behandlet med aktivt kul og derpå syrnet til udskillelse af krystaller. Krystallerne blev udvundet ved filtrering og vasket med vand. Omkrystallisation fra en blanding af dioxan og vand gav 6,9 g 3,4-bis(salicylamido)-benzoesyre med et smp. 305-307°C (sønderdeling).The reaction mixture was added to 200 ml of cold dilute hydrochloric acid, and the undissolved mixture of oil and powdered solid was isolated. The mixture was dissolved in ca. 100 ml of aqueous 1 N sodium hydroxide solution, and the solution is treated with activated charcoal and then acidified to separate crystals. The crystals were recovered by filtration and washed with water. Recrystallization from a mixture of dioxane and water gave 6.9 g of 3,4-bis (salicylamido) benzoic acid, m.p. 305-307 ° C (dec.).

Analyse:Analysis:

Beregnet: G 64,3, H 4,1, N 7,1 (7=)Calculated: G 64.3, H 4.1, N 7.1 (7 =)

Fundet: C 64,4, H 4,1, N 6,8 (%)Found: C 64.4, H 4.1, N 6.8 (%)

Eksempel 3Example 3

En blanding af 3,32 g methyl-2,5-diaminobenzoat, 5,8 ml triethylamin og 20 ml tetrahydrofuran blev dråbevis sat til en opløsning af 8,7 g 2-acetoxyben-zoylchlorid i 150 ml tetrahydrofuran i løbet af 30 minutter under omrøring ved 5-10°C. Efter afslutning af tilsætningen blev blandingen omrørt ved stuetemperatur i 1 time og derpå udhældt i 500 ml isvand til udskillelse af krystaller. Krystallerne blev udvundet ved filtrering, vasket med vand og tørret i luft. Omkrystallisation fra ethylacetat gav 8,1 g methyl-2,5-bis(2*-acetoxybenzamido)-ben-zoat med et smp. 170-171°G.A mixture of 3.32 g of methyl 2,5-diaminobenzoate, 5.8 ml of triethylamine and 20 ml of tetrahydrofuran was added dropwise to a solution of 8.7 g of 2-acetoxybenzoyl chloride in 150 ml of tetrahydrofuran over 30 minutes. stirring at 5-10 ° C. After completion of the addition, the mixture was stirred at room temperature for 1 hour and then poured into 500 ml of ice water to separate crystals. The crystals were recovered by filtration, washed with water and dried in air. Recrystallization from ethyl acetate gave 8.1 g of methyl 2,5-bis (2 * -acetoxybenzamido) benzoate with a m.p. 170-171 ° G.

Analyse:Analysis:

Beregnet: G 63,7, H 4,5, N 5,7 (7.)Calculated: G 63.7, H 4.5, N 5.7 (7.)

Fundet: C 63,5, H 4,6, N 5,7 (%)Found: C 63.5, H 4.6, N 5.7 (%)

Eksempel 4 I 150 ml methanol blev opløst 5,3 g methyl-2,5-bis(2'-acetoxybenzamido)-benzoat fremstillet som beskrevet i eksempel 3. Til opløsningen blev sat 2,5 g natriumcarbonat opløst i 40 ml vand, og derpå blev blandingen cmrørt ved stuetemperatur i 30 minutter. Blandingen blev udhældt i 500 ml vand indeholdende 10 ml eddikesyre til udskillelse af krystaller. Krystallerne blev udvundet ved filtrering, vasket med vand, tørret og omkrystalliseret fra ethylacetat til opnåelse af 3,8 g methyl-2,5-bis(salicylamido)-benzoat med et smp. mellem 243-244°G.Example 4 In 150 ml of methanol was dissolved 5.3 g of methyl 2,5-bis (2'-acetoxybenzamido) benzoate prepared as described in Example 3. To the solution was added 2.5 g of sodium carbonate dissolved in 40 ml of water, and then the mixture was stirred at room temperature for 30 minutes. The mixture was poured into 500 ml of water containing 10 ml of acetic acid to separate crystals. The crystals were recovered by filtration, washed with water, dried and recrystallized from ethyl acetate to give 3.8 g of methyl 2,5-bis (salicylamido) benzoate, m.p. between 243-244 ° G.

Analyse:Analysis:

Beregnet: G 65,0, H 4,5, N 6,9 (7.)Calculated: G 65.0, H 4.5, N 6.9 (7.)

Fundet: G 65,1, H 4,6, N 7,0 (7.) 9 142543Found: G 65.1, H 4.6, N 7.0 (7.) 9

Eksempe1 5Example1 5

En vandig opløsning af 4 g natriumhydroxid i 10 ml vand blev sat til en blanding af 5,3 g methyl-2,5-bis-(2,-acetoxybenzamido)-benzoat, fremstillet som beskrevet i eksempe1 3, og 100 ml methanol. Den resulterende blanding blev ran-rørt ved stuetemperatur i 20-30 timer og derpå udhældt i 500 ml vand indeholdende 10 ml eddikesyre til udskillelse af krystaller. Krystallerne blev udvundet ved filtrering, vasket med vand og rankrystalliseret fra en blanding af dioxan og vand til opnåelse af 3,5 g 2,5-bis(salicylamido)-benzoesyre med et smp. mellem 280 og 283°C (sønderdeling).An aqueous solution of 4 g of sodium hydroxide in 10 ml of water was added to a mixture of 5.3 g of methyl 2,5-bis (2, -acetoxybenzamido) benzoate, prepared as described in Example 13, and 100 ml of methanol. The resulting mixture was stirred at room temperature for 20-30 hours and then poured into 500 ml of water containing 10 ml of acetic acid to separate crystals. The crystals were recovered by filtration, washed with water and rank crystallized from a mixture of dioxane and water to give 3.5 g of 2,5-bis (salicylamido) benzoic acid, m.p. between 280 and 283 ° C (dec.).

Analyse:Analysis:

Beregnet: C 64,3, H 4,1, N 7,1 (%)Calculated: C 64.3, H 4.1, N 7.1 (%)

Fundet: C 64,3, H 4,0, N 6,9 (%)Found: C 64.3, H 4.0, N 6.9 (%)

Eksempel 6Example 6

En blanding af 6,64 g methyl-2,4-diaminobenzoat, 11,5 ml diethylamin og 50 ml tetrahydrofuran blev dråbevis sat til en opløsning af 17,4 g 2-acetoxy-benzoylchlorid i 300 ml tetrahydrofuran i løbet af 1/2-1 time, under omrøring ved 5-10°C. Omrøringen blev derpå fortsat ved stuetemperatur i 2 timer. Den resulterende reaktionsblanding blev udhældt i 10,5 liter fortyndet saltsyre til udskillelse af krystaller. Krystallerne blev udvundet ved filtrering, vasket med vand, tørret og rankrystalliseret fra ethylacetat til opnåelse af 10 g methyl- 2,4-bis(2'-acetoxybenzamido)-benzoat med smp. 143-145°C.A mixture of 6.64 g of methyl 2,4-diaminobenzoate, 11.5 ml of diethylamine and 50 ml of tetrahydrofuran was added dropwise to a solution of 17.4 g of 2-acetoxybenzoyl chloride in 300 ml of tetrahydrofuran over 1/2 -1 hour, with stirring at 5-10 ° C. Stirring was then continued at room temperature for 2 hours. The resulting reaction mixture was poured into 10.5 liters of dilute hydrochloric acid to separate crystals. The crystals were recovered by filtration, washed with water, dried and rank crystallized from ethyl acetate to give 10 g of methyl 2,4-bis (2'-acetoxybenzamido) benzoate with m.p. 143-145 ° C.

Analyse:Analysis:

Beregnet: G 63,7, H 4,5, N 5,7 (%)Calculated: G 63.7, H 4.5, N 5.7 (%)

Fundet: C 63,5, H 4,3, N 5,6 (%)Found: C 63.5, H 4.3, N 5.6 (%)

Eksempel 7 På lignende måde som beskrevet i eksempel 4 blev methyl-2,4-bis-(2'-acetoxybenzamido)-benzoat hydrolyseret ved hjælp af natriumcarbonat til opnåelse af krystaller. Omkrystallisation af krystallerne fra en blanding af acetone, dioxan og vand gav methyl-2,4-bis-(salicylamido)"benzoat med et smp. 259-260°C. (Udbytte 82%)·Example 7 In a similar manner to Example 4, methyl 2,4-bis (2'-acetoxybenzamido) benzoate was hydrolyzed by sodium carbonate to give crystals. Recrystallization of the crystals from a mixture of acetone, dioxane and water gave methyl 2,4-bis- (salicylamido) benzoate, mp 259-260 ° C (Yield 82%) ·

Analyse:Analysis:

Beregnet: G 65,0, H 4,5, N 6,9 (%)Calculated: G 65.0, H 4.5, N 6.9 (%)

Fundet: C 65,1, H 4,4, N 6,8 (%) i 142543 ίοFound: C 65.1, H 4.4, N 6.8 (%) in 142543

Eksempel 8 På lignende måde som beskrevet i eksempel 5 blev 2,4-bis(2’-acetoxyben-zamido)-benzoat, fremstillet som beskrevet i eksempel 6, hydrolyseret ved hjælp af natriumhydroxid. Omkrystallisation af det hydrolyserede produkt fra en blanding af dioxan og vand gav 2,4-bis(salicylamido)-benzoesyre med et smp. mellem 250-252°C (sønderdeling). (Udbytte 85%).Example 8 In a similar manner as described in Example 5, 2,4-bis (2'-acetoxybenzamido) benzoate, prepared as described in Example 6, was hydrolyzed by sodium hydroxide. Recrystallization of the hydrolyzed product from a mixture of dioxane and water gave 2,4-bis (salicylamido) benzoic acid, m.p. between 250-252 ° C (dec.). (Yield 85%).

Analyse:Analysis:

Beregnet: C 64,3, H 4,1, N 7,1 (%)Calculated: C 64.3, H 4.1, N 7.1 (%)

Fundet: G 64,1, H 4,2, N 6,9 (%)Found: G 64.1, H 4.2, N 6.9 (%)

Eksempel 9Example 9

En oplosning af 3,86 ml phosphoroxychlorid i 20 ml tetrahydrofuran blev dråbevis sat til en blanding af 3,3 g methyl-2,4-diaminobenzoat, 6,7 g 2-methoxy-benzoesyre, 1,8 g triethylamin og 100 ml tetrahydrofuran i løbet af 1-2 timer under omrøring ved -10 til -5°C efterfulgt af omrøring ved stuetemperatur i 1 time. Den resulterende blanding blev derpå udhældt i 1 liter isvand til udfælde1-se af krystaller. Krystallerne blev udvundet ved filtrering, vasket med vand, tørret og omkrystalliseret fra ethylacetat til opnåelse af 7,2 g methyl-2,4-bis(2,-methoxybenzamido)-benzoat med smp. 166-167°C.A solution of 3.86 ml of phosphorus oxychloride in 20 ml of tetrahydrofuran was added dropwise to a mixture of 3.3 g of methyl 2,4-diaminobenzoate, 6.7 g of 2-methoxybenzoic acid, 1.8 g of triethylamine and 100 ml of tetrahydrofuran. over 1-2 hours with stirring at -10 to -5 ° C followed by stirring at room temperature for 1 hour. The resulting mixture was then poured into 1 liter of ice water to precipitate crystals. The crystals were recovered by filtration, washed with water, dried and recrystallized from ethyl acetate to give 7.2 g of methyl 2,4-bis (2, -methoxybenzamido) benzoate, m.p. 166-167 ° C.

Analyse:Analysis:

Beregnet: C 66,4, H 5,1, N 6,5 (%)Calculated: C 66.4, H 5.1, N 6.5 (%)

Fundet: C 66,6, H 5,1, N 6,5 (%)Found: C 66.6, H 5.1, N 6.5 (%)

Eksempel 10 5 g methyl-2,4-bis(2'-methoxybenzamido)-benzoat, fremstillet som beskrevet i eksempel 9, blev blandet med 250 ml dioxan, 3 g kaliumhydroxid og 50 ml vand, hvorpå blandingen blev omrørt ved stuetemperatur i 20-30 timer. Blandingen blev derpå udhældt i 1,5 ml isvand.indeholdende 20 ml eddikesyre til udskillelse af krystaller. Krystallerne blev udvundet ved filtrering, vasket med vand og omkrystalliseret fra ethanol-vand til opnåelse af 3,6 g 2,4-bis(2'-methoxy-benzamido)-benzoesyre med smp. 232-233°C.Example 10 5 g of methyl 2,4-bis (2'-methoxybenzamido) benzoate, prepared as described in Example 9, were mixed with 250 ml of dioxane, 3 g of potassium hydroxide and 50 ml of water, and the mixture was stirred at room temperature for 20 minutes. -30 hours. The mixture was then poured into 1.5 ml of ice water containing 20 ml of acetic acid to separate crystals. The crystals were recovered by filtration, washed with water and recrystallized from ethanol-water to give 3.6 g of 2,4-bis (2'-methoxy-benzamido) -benzoic acid, m.p. 232-233 ° C.

Analyse:Analysis:

Beregnet: C 65,7, H 4,8, N 6,7 (%)Calculated: C 65.7, H 4.8, N 6.7 (%)

Fundet: C 65,4, H 4,9, N 6,7 (%) 11 142543Found: C 65.4, H 4.9, N 6.7 (%)

Eksempel 11 I 250 ml tetrahydrofuran blev opløst 2 g 2,4-diaminobenzamid og 3,7 ml triethylamin, og til opløsningen blev dråbevis sat en opløsning af 4,5 g 2-me- thoxybenzoylchlorid i 20 ml tetrahydrofuran i løbet af 1 time, hvorpå der blev omrørt ved stuetemperatur i 1 time. Reaktionsblandingen blev derpå udhældt i 1,5 liter fortyndet saltsyre til udskillelse af krystaller. Krystallerne blev udvundet ved filtrering, vasket med vand og omkrystalliseret fra en blanding af dime-thylformamid og vand til opnåelse af 4,1 g 2,4-bis(2,-methoxybenzamido)-benzamid med smp. 270-272°C (sønderdeling).Example 11 In 250 ml of tetrahydrofuran were dissolved 2 g of 2,4-diaminobenzamide and 3.7 ml of triethylamine, and to the solution was added dropwise a solution of 4.5 g of 2-methoxybenzoyl chloride in 20 ml of tetrahydrofuran over 1 hour. and then stirred at room temperature for 1 hour. The reaction mixture was then poured into 1.5 liters of dilute hydrochloric acid to separate crystals. The crystals were recovered by filtration, washed with water and recrystallized from a mixture of dimethylformamide and water to give 4.1 g of 2,4-bis (2, -methoxybenzamido) benzamide with m.p. 270-272 ° C (dec.).

Analyse:Analysis:

Beregnet: C 65,9, H 5,1, N 10,0 (%)Calculated: C 65.9, H 5.1, N 10.0 (%)

Fundet: C 65,7, H 5,3, N 10,1 (7.)Found: C 65.7, H 5.3, N 10.1 (7.)

Eksempel 12 I 40 ml tetrahydrofuran blev opløst 4,35 g 2-acetoxybenzoylchlorid og til opløsningen blev sat 1,5 g 3,5-diaminobenzamid. En opløsning af 3,08 ml triethylamin i 10 ml tetrahydrofuran blev sat dråbevis til reaktionsblandingen i løbet af 1,5 timer under omrøring ved stuetemperatur efterfulgt af omrøring ved stuetemperatur i 2 timer. Den således opnåede reaktionsblanding blev udhældt i 300 ml kold fortyndet saltsyre og ekstraheret med ethylacetat. Det organiske lag blev vasket med vand, tørret over natriumsulfat og koncentreret under reduceret tryk. Ctakrystallisation af remanensen fra varm benzen gav 2,1 g 3,5-bis (2'-acetoxybenzamido)-benzamid med et smp. over 105°C (sønderdeling).Example 12 In 40 ml of tetrahydrofuran was dissolved 4.35 g of 2-acetoxybenzoyl chloride and 1.5 g of 3,5-diaminobenzamide was added to the solution. A solution of 3.08 ml of triethylamine in 10 ml of tetrahydrofuran was added dropwise to the reaction mixture over 1.5 hours with stirring at room temperature followed by stirring at room temperature for 2 hours. The reaction mixture thus obtained was poured into 300 ml of cold dilute hydrochloric acid and extracted with ethyl acetate. The organic layer was washed with water, dried over sodium sulfate and concentrated under reduced pressure. Crystallization of the residue from hot benzene gave 2.1 g of 3,5-bis (2'-acetoxybenzamido) benzamide with a m.p. above 105 ° C (dec.).

Analyse:Analysis:

Beregnet: C 63,2, H 4,5, N 8,8 (%)Calculated: C 63.2, H 4.5, N 8.8 (%)

Fundet: C 63,0, H 4,4, N 8,6 (%)Found: C 63.0, H 4.4, N 8.6 (%)

Eksempel 13 På lignende måde som beskrevet i eksempel 4 blev 3,5-bis(2'-acetoxyben-zamido)-benzamld, fremstillet som beskrevet i eksempel 12, hydrolyseret med natri umcar bonat. Omkrystallisation af det hydrolyserede produkt fra en blanding af ethanol og vand gav 3,8-bis(salicylamido)-benzamid med smp. 276-277°C.Example 13 In a similar manner as described in Example 4, 3,5-bis (2'-acetoxybenzamido) benzamide prepared as described in Example 12 was hydrolyzed with sodium carbonate. Recrystallization of the hydrolyzed product from a mixture of ethanol and water gave 3.8-bis (salicylamido) benzamide, m.p. 276-277 ° C.

(Udbytte 83%).(Yield 83%).

Analyse:Analysis:

Beregnet: C 64,4, H 4,4, N 10,7 (%)Calculated: C 64.4, H 4.4, N 10.7 (%)

Fundet: C 64,1, H 4,7, N 10,7 (%) 162543 12Found: C 64.1, H 4.7, N 10.7 (%)

Eksempel 14Example 14

En opløsning af 16,2 g 2-methoxybenzoylchlorid i 40 ml dioxan blev sat dråbevis til en blanding af 4,6 g 3,5-diaminobenzoesyre, 15,3 g kaliumacetat og 70 ml vand i løbet af 30 minutter under omrøring ved 0-5°G, efterfulgt af omrøring ved stuetemperatur i 1 time og derpå ved 50°G i 1 yderligere time. Reaktionsblandingen blev afkølet og udhældt i 100 ml fortyndet saltsyre til udskillelse af krystaller. Krystallerne blev udvundet ved filtrering, vasket med vand og omkrystalliseret fra ethanol til opnåelse af 6 g 3,5-bis(2'-methoxybenzamido)-benzoesyre med et smp. 253-254°C.A solution of 16.2 g of 2-methoxybenzoyl chloride in 40 ml of dioxane was added dropwise to a mixture of 4.6 g of 3,5-diaminobenzoic acid, 15.3 g of potassium acetate and 70 ml of water over 30 minutes with stirring at 0 ° C. 5 ° G, followed by stirring at room temperature for 1 hour and then at 50 ° G for 1 additional hour. The reaction mixture was cooled and poured into 100 ml of dilute hydrochloric acid to separate crystals. The crystals were recovered by filtration, washed with water and recrystallized from ethanol to give 6 g of 3,5-bis (2'-methoxybenzamido) benzoic acid, m.p. 253-254 ° C.

Analyse:Analysis:

Beregnet: C 65,7, H 4,8, N 6,7 (%)Calculated: C 65.7, H 4.8, N 6.7 (%)

Fundet: C 65,5, H 4,9, N 6,5 (%)Found: C 65.5, H 4.9, N 6.5 (%)

Eksempel 15 I 200 ml pyridin blev opløst 8,3 methyl-2,4-diaminobenzoat, og til op-løseningen sat en opløsning af 4,4 ml phosphortrichlorid i 30 ml pyridin under køling med is, hvorpå der blev omrørt ved 50-70°C i 1 time. Til blandingen blev sat 21 g salicylsyre, hvorpå der blev opvarmet til 90°C i 3 timer. Efter afkøling af blandingen ved henstand blev ikke opløste stoffer filtreret fra, og filtratet koncentreret under reduceret tryk. Til koncentratet blev sat kold fortyndet saltsyre til udskillelse af krystaller. Krystallerne blev udvundet ved filtrering, vasket med vand og omkrystalliseret fra en acetone-dioxan-vand-blanding til opnåelse af 11,1 g methyl-2,4-bis(salicylamido)-benzoat med smp. 259-260°C.Example 15 In 200 ml of pyridine was dissolved 8.3 methyl-2,4-diaminobenzoate and to the solution was added a solution of 4.4 ml of phosphorus trichloride in 30 ml of pyridine under ice-cooling and stirred at 50-70 ° C for 1 hour. To the mixture was added 21 g of salicylic acid and then heated to 90 ° C for 3 hours. After cooling the mixture upon standing, solutes were filtered off and the filtrate concentrated under reduced pressure. To the concentrate was added cold dilute hydrochloric acid to separate crystals. The crystals were recovered by filtration, washed with water and recrystallized from an acetone-dioxane-water mixture to give 11.1 g of methyl 2,4-bis (salicylamido) benzoate, m.p. 259-260 ° C.

Det blev bekræftet, at produktet var identisk med produktet i eksempel 7.It was confirmed that the product was identical to the product of Example 7.

Eksempe1 16Example1 16

Ved en lignende metode som den i eksempel 15 beskrevne blev methyl-2,5-diaminobenzoat kondenseret med salicylsyre ved hjælp af phosphortrichlorid til opnåelse af methyl-2,5-bis(salicylamido)-benzoat (udbytte 54%). Produktet viste sig at være identisk med det, der blev opnået i eksempel 4.By a method similar to that described in Example 15, methyl 2,5-diaminobenzoate was condensed with salicylic acid by phosphorus trichloride to give methyl 2,5-bis (salicylamido) benzoate (yield 54%). The product was found to be identical to that obtained in Example 4.

Eksempel 17 1 g 3,5-bis(salicylamido)-benzoesyre,fremstillet som beskrevet i eksempel 1, blev behandlet med 30 ml eddikesyreanhydrid og 3 ml pyridin efterfulgt af omrøring ved stuetemperatur i 3 timer. Til reaktionsblandingen blev sat 100 ml isvand til udskillelse af krystaller, der blev udvundet ved filtrering. Omkrystallisation fra en dioxan-vand-blanding gav 0,8 g 3,5-bis(2*-acetoxy-benzamido)-benzoesyre med smp. 211-212°C (sønderdeling).Example 17 1 g of 3,5-bis (salicylamido) benzoic acid, prepared as described in Example 1, was treated with 30 ml of acetic anhydride and 3 ml of pyridine followed by stirring at room temperature for 3 hours. To the reaction mixture was added 100 ml of ice water to separate crystals which were recovered by filtration. Recrystallization from a dioxane-water mixture gave 0.8 g of 3,5-bis (2 * -acetoxy-benzamido) benzoic acid, m.p. 211-212 ° C (dec.).

13 14254313 142543

Analyse :Analysis:

Beregnet: C 63,0, H 4,2, N 5,9 (%)Calculated: C 63.0, H 4.2, N 5.9 (%)

Fundet: C 62,8, H 4,4, N 5,7 (%)Found: C 62.8, H 4.4, N 5.7 (%)

Eksempel 18Example 18

Til en blanding af 4,9 g 2,4-diaminobenzoesyre, 12 g natriumacetat, 90 ml methylenchlorid og 90 ml vand blev sat 19,2 g 2-acetoxybenzoylchlorid under omrøring ved 5-10°C, efterfulgt af fortsat omrøring ved 5-15°C i 4 timer.To a mixture of 4.9 g of 2,4-diaminobenzoic acid, 12 g of sodium acetate, 90 ml of methylene chloride and 90 ml of water was added 19.2 g of 2-acetoxybenzoyl chloride with stirring at 5-10 ° C, followed by continued stirring at 5- 15 ° C for 4 hours.

De udskilte krystaller blev udvundet ved filtrering, vasket med vand og derpå med methylenchlorid og omhyggeligt blandet med 70 ml methanol. Til blandingen blev sat 30 ml vand, hvorpå den blev henstillet til udskillelse af krystaller. Krystallerne blev udvundet ved filtrering og omkrystalliseret fra 90%'s vandig methanol til opnåelse af 7,5 g 2,4-bis(2'-acetoxybenzamido)-benzoesyre med smp. 194-195°C.The separated crystals were recovered by filtration, washed with water and then with methylene chloride and carefully mixed with 70 ml of methanol. To the mixture was added 30 ml of water, and it was left to separate crystals. The crystals were recovered by filtration and recrystallized from 90% aqueous methanol to give 7.5 g of 2,4-bis (2'-acetoxybenzamido) benzoic acid, m.p. 194-195 ° C.

Analyse:Analysis:

Beregnet: C 63,0, H 4,2, N 5,9 (¾)Calculated: C 63.0, H 4.2, N 5.9 (¾)

Fundet: C 62,7, H 4,1, N 6,0 (%)Found: C 62.7, H 4.1, N 6.0 (%)

Eksempel 19 På lignende måde som beskrevet i eksempel 1 blev 2,4-diaminobenzoesyre kondenseret med 2-ethoxybenzoylchlorid til opnåelse af 2,4-bis(2'-ethoxybenza-mido)-benzoesyre med et smp. 225-226°C.Example 19 In a similar manner as described in Example 1, 2,4-diaminobenzoic acid was condensed with 2-ethoxybenzoyl chloride to give 2,4-bis (2'-ethoxybenzamido) -benzoic acid, m.p. 225-226 ° C.

Analyse:Analysis:

Beregnet: C 67,0%, H 5,4, N 6,3 (%)Calculated: C 67.0%, H 5.4, N 6.3 (%)

Fundet: C 66,7, H 5,5, N 6,0 (%)Found: C 66.7, H 5.5, N 6.0 (%)

Eksempel 20 På lignende måde som beskrevet i eksempel 12 blev 3,5-diaminobenzamid kondenseret med 2-methoxybenzoylchlorid til opnåelse af 3,5-bis(2'-methoxyben-zamido)-benzamid med et smp. 226-227°C.Example 20 In a similar manner as described in Example 12, 3,5-diaminobenzamide was condensed with 2-methoxybenzoyl chloride to give 3,5-bis (2'-methoxybenzamido) benzamide with a m.p. 226-227 ° C.

Analyse:Analysis:

Beregnet: C 65,9, H 5,1, N 10,0 (%)Calculated: C 65.9, H 5.1, N 10.0 (%)

Fundet: C 65,5, H 5,3, N 10,1 (%)Found: C 65.5, H 5.3, N 10.1 (%)

Eksempel 21 På lignende måde som beskrevet i eksempel 6 blev ethyl-2,4-diaminobenzo-at kondenseret med 2-acetoxybenzoylchlorid til opnåelse af ethyl-2,4-bis(2'-acetoxybenzamido)-benzoat med et smp. 154-155°C.Example 21 In a similar manner as described in Example 6, ethyl 2,4-diaminobenzoate was condensed with 2-acetoxybenzoyl chloride to give ethyl 2,4-bis (2'-acetoxybenzamido) benzoate with a m.p. 154-155 ° C.

14 14254314 142543

AnalysetAnalyset

Beregnet: G 64,3, H 4,8, N 5,6 (%)Calculated: G 64.3, H 4.8, N 5.6 (%)

Fundet: G 64,4, H 4,9, N 5,5 (%)Found: G 64.4, H 4.9, N 5.5 (%)

Eksempel 22 På lignende måde som beskrevet i eksempel 6 blev ethyl-2,4-diaminobenzo-at kondenseret med 2-n-butoxybenzoylchlorid til opnåelse af ethyl-2,4-bis(2'-n-butoxybenzamido).-benzoat med et smp. 134-136°C.Example 22 In a similar manner as described in Example 6, ethyl 2,4-diaminobenzoate was condensed with 2-n-butoxybenzoyl chloride to give ethyl 2,4-bis (2'-n-butoxybenzamido) benzoate with a mp. 134-136 ° C.

Analyse:Analysis:

Beregnet: G 69,9, H 6,8, N 5,3 (%)Calculated: G 69.9, H 6.8, N 5.3 (%)

Fundet: G 70,0, H 6,8, N 5,3 (%)Found: G 70.0, H 6.8, N 5.3 (%)

Eksempel 23 På lignende måde som beskrevet i eksempel 6 blev n-butyl-2,4-diamino-benzoat kondenseret med 2-acetoxybenzoylchlorid til opnåelse af n-butyl-2,4-bis (21-acetoxybenzamido)-benzoat med smp. 149-152°C.Example 23 In a similar manner to Example 6, n-butyl-2,4-diamino-benzoate was condensed with 2-acetoxybenzoyl chloride to give n-butyl-2,4-bis (21-acetoxybenzamido) benzoate, m.p. 149-152 ° C.

Analyse:Analysis:

Beregnet: C 65,4, H 5,3, N 5,3 (%)Calculated: C 65.4, H 5.3, N 5.3 (%)

Fundet: C 65,7, H 5,2, N 5,3 (%)Found: C 65.7, H 5.2, N 5.3 (%)

Eksempe1 24 På lignende måde som beskrevet i eksempel 6 blev raethyl-2,4-diaminoben-zoat kondenseret med 2-ethoxybenzoylchlorid til opnåelse af methyl-2,4-bis(2'-ethoxybenzamido)-benzoat med et smp. 199-200°C.Example 24 In a similar manner as described in Example 6, ethyl 2,4-diamino benzoate was condensed with 2-ethoxybenzoyl chloride to give methyl 2,4-bis (2'-ethoxybenzamido) benzoate, m.p. 199-200 ° C.

Analyse:Analysis:

Beregnet: C 67,5, H 5,7, N 6,1 (%)Calculated: C 67.5, H 5.7, N 6.1 (%)

Fundet: C 67,5, H 5,5, N 6,0 (%)Found: C 67.5, H 5.5, N 6.0 (%)

DK166774AA 1973-03-27 1974-03-26 Analogous process for the preparation of bis (benzamido) benzoic acid derivatives or pharmaceutically acceptable salts thereof. DK142543B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3415273A JPS5715585B2 (en) 1973-03-27 1973-03-27
JP3415273 1973-03-27

Publications (2)

Publication Number Publication Date
DK142543B true DK142543B (en) 1980-11-17
DK142543C DK142543C (en) 1981-07-20

Family

ID=12406215

Family Applications (1)

Application Number Title Priority Date Filing Date
DK166774AA DK142543B (en) 1973-03-27 1974-03-26 Analogous process for the preparation of bis (benzamido) benzoic acid derivatives or pharmaceutically acceptable salts thereof.

Country Status (12)

Country Link
JP (1) JPS5715585B2 (en)
AR (1) AR206399A1 (en)
BE (1) BE812869A (en)
CH (1) CH593921A5 (en)
CS (1) CS168472B2 (en)
DK (1) DK142543B (en)
ES (1) ES424668A1 (en)
HU (1) HU167255B (en)
MX (1) MX3089E (en)
NL (1) NL7404022A (en)
SE (1) SE406463B (en)
SU (1) SU560530A3 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2395952T3 (en) * 2005-03-16 2013-02-18 Toyama Chemical Co., Ltd. New derivative of anthranilic acid or a salt thereof

Also Published As

Publication number Publication date
HU167255B (en) 1975-09-27
CH593921A5 (en) 1977-12-30
BE812869A (en) 1974-07-15
CS168472B2 (en) 1976-06-29
MX3089E (en) 1980-03-31
NL7404022A (en) 1974-10-01
AR206399A1 (en) 1976-07-23
ES424668A1 (en) 1976-06-01
SU560530A3 (en) 1977-05-30
JPS49117442A (en) 1974-11-09
JPS5715585B2 (en) 1982-03-31
DK142543C (en) 1981-07-20
SE406463B (en) 1979-02-12

Similar Documents

Publication Publication Date Title
NO142441B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE CARBOXYLIC ACID DERIVATIVES
SE416205B (en) PROCEDURE FOR THE PREPARATION OF 7-TRIFLUORMETHYL METER CAPTAACETAMIDOCEPHALOSPORINES
SU1282818A3 (en) Method of producing orthocondensed derivatives of pyrrole
SU847922A3 (en) Method of preparing d-7-/alpha-(4-oxy-6-methylnicotineamido)-3-(1-methyl)acetamido/-3-(1-methyltetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic acid
GB2038838A (en) Immunogen conjugates of diphenyldantoin
US4539326A (en) 5-Oxo-5H-(1)benzopyrano(2,3-b)pyridine derivatives, their production and use as anti-inflammatory agents
SU831074A3 (en) Method of preparing benzimidazole derivatives
DK142543B (en) Analogous process for the preparation of bis (benzamido) benzoic acid derivatives or pharmaceutically acceptable salts thereof.
Smith et al. 311. The alkaloids of ergot. Part VII. iso Ergine and iso lysergic acids
US3585214A (en) Hydroxyl derivatives of coumarine and processes for the preparation thereof
US3872108A (en) Novel chromone derivatives and the production thereof
US4743704A (en) Esters of salsalate with guaiacol, for treating phlogistic bronchopneumopathies
Fried et al. Neogermitrine, a New Ester Alkaloid from Veratrum Viride1
JPH0692410B2 (en) Novel benzofuroquinoline derivative
EP0121806B1 (en) Pyrazolo(1,5-a)pyridine derivatives and compositions containing them
US3953496A (en) Bis(benzamido)-benzoic acid derivatives
Webb The Chemistry of Bipyrryls. II. The Preparation and Resolution of A 1, 1'-Disubstituted 2, 2'-Bipyrryl Exhibiting Restricted Rotation
US3268511A (en) 5, 5-diloweralkyl-4-omicron-lower alkyl-2, 3-cyclocarbonato-l-pyranosyl halides
Baker et al. 148. The structures of buddleoflavonoloside (linarin) and of buddleoflavonol (acacetin)
US3367948A (en) Novel d-threo-1-phenyl-2-amino-propane-1, 3-diol-derivatives
US2345635A (en) Di-esters of 3,3&#39;-methylenebis (4-hydroxycoumarin) and process of making them
BARONE et al. A 2-Trifluoromethyl Analog of Thiamin1
US2874156A (en) Substituted l
Amin Sammour Action of Primary Aliphatic Amines on 2-Methyl-1, 4-α-naphthopyrone
HAYAKAWA et al. MICROBIOLOGICAL DEGRADATION OF BILE ACIDS VII. PARTIAL SYNTHESIS OF 3, 12-DIKETO. Δ 4, 6-CHOLADIENIC ACID AND ITS DERIVATIVES FROM CHOLIC ACID